GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Windlas Biotech Ltd

Windlas Biotech Board Changes: Two Directors Appointed, One Resigns

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 12 Oct 2026, 06:21 PM IST  ·  BSE ID: a57f0abf-6300-452c-aed2-62eb04825a03
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has added two directors and accepted the resignation of one, effective immediately.
🤖 AI Summary
  • Board of Directors approved changes effective October 12, 2026.
  • Mr. Aashish Mehra appointed Additional/Independent Director for five years.
  • Mr. Soni Saran Singh appointed Additional/Independent Director for five years.
  • Mr. Vivek Dhariwal resigned as Independent Director citing personal reasons.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Director Appointment Term
five consecutive years
Director Resignation Effective
close of business hours on October 12, 2026
🏢 How This Affects the Company
📈
Business Impact
Changes in board composition may influence future strategic decisions and corporate governance oversight.
💰
Financial Impact
No immediate financial impact is discernible from these board appointments and resignation.
⚙️
Operational Impact
The operational impact is limited to changes in board meeting attendance and decision-making dynamics.
⚠️
Risk Impact
The departure of an Independent Director might necessitate a reassessment of specific oversight functions until replacements are fully integrated.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time. Shareholder approval is needed for the appointments.
👤
Who Is Affected
All shareholders are affected as board composition impacts corporate governance and strategic direction.
🔍
Management Signal
The appointments signal management's intent to maintain board stability and comply with governance norms.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder meeting announcement for director appointment approval.
Confirmation of new director roles on board committees.
Future board meeting minutes for strategic decisions.
LOW RISK Standard board composition change with no immediate financial or operational implications.
💡 Investor Takeaway
Windlas Biotech appointed two new Independent Directors, Mr. Aashish Mehra and Mr. Soni Saran Singh, for five-year terms, while Mr. Vivek Dhariwal resigned.
❓ Frequently Asked Questions
Who has been appointed as Additional/Independent Director at Windlas Biotech?
Mr. Aashish Mehra and Mr. Soni Saran Singh have been appointed as Additional/Independent Directors.
For how long have the new directors been appointed at Windlas Biotech?
The new directors have been appointed for a period of five consecutive years.
Who resigned as an Independent Director from Windlas Biotech?
Mr. Vivek Dhariwal resigned as an Independent Director from Windlas Biotech.
When were the board changes at Windlas Biotech effective?
The board changes were effective from October 12, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.